Trial intelligence / Profile preview

CICLADE: Cyclosporine A protection in thrombolysed acute myocardial infarction

2008-006211-21Phase 3Active

Sponsor
Hospices Civils de Lyon
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ciclosporin in myocardial infarction (MI), sponsored by Hospices Civils de Lyon. Primary endpoint: Primary endpoint: infarct size. Started Jun 2009; status: active.

02

Drugs

ciclosporin
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2008-006211-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006211-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call